✦ LIBER ✦

Single agent gemcitabine in the second-line treatment of advanced non-small cell lung cancer after treatment with taxane + platinum regimens

✍ Scribed by Ugur Coskun; Ali Osman Kaya; Süleyman Buyukberber; Mustafa Benekli; Aytug Uner; Mustafa Dikilitas; Banu Ozturk; Ramazan Yildiz; Secil Ozkan; Emel Yaman; Deniz Yamac

Book ID: 107576637
Publisher: Springer US
Year: 2007
Tongue: English
Weight: 147 KB
Volume: 25
Category: Article
ISSN: 1357-0560
DOI: 10.1007/s12032-007-9005-3

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase II study of weekly chemotherapy wi

Phase II study of weekly chemotherapy with paclitaxel and gemcitabine as second-line treatment for advanced non-small cell lung cancer after treatment with platinum-based chemotherapy

✍ Kiyoshi Mori; Yukari Kamiyama; Tetsuro Kondo; Yasuhiko Kano; Tetsuro Kodama 📂 Article 📅 2006 🏛 Springer 🌐 English ⚖ 330 KB

Combination versus sequential single-age

Combination versus sequential single-agent chemotherapy in the treatment of patients with advanced non-small cell lung cancer

✍ Niell, Harvey B. ;Griffin, John P. ;Hunter, Robert F. ;Meredith, Charlotte A. ;S 📂 Article 📅 1989 🏛 John Wiley and Sons 🌐 English ⚖ 716 KB

We have carried out a randomized phase Ill study in 105 patients with advanced nonsmall cell lung cancer, comparing a fourdrug cisplatin-mitomycin-based combination chemotherapy regimen t o sequential single-agent therapy. The combination chemotherapy regimen consisted of mitomycin C (10 mg/m2), vin

Economic evaluation of gemcitabine singl

Economic evaluation of gemcitabine single agent therapy compared with standard treatment in stage IIIB and IV non-small cell lung cancer

✍ Gunnel Ragnarson Tennvall; Jan-Olof Fernberg 📂 Article 📅 1998 🏛 Springer US 🌐 English ⚖ 978 KB

Clinical study of comparing LP and TP re

Clinical study of comparing LP and TP regimens in the treatment of advanced non-small cell lung cancer

✍ Jianfei Gao; Sha Guan; Wenjuan Deng; Guochao Qiu; Zhiguo Rao; Bicheng Zhang 📂 Article 📅 2010 🏛 Springer 🌐 English ⚖ 221 KB

A phase I–II study of bi-weekly gemcitab

A phase I–II study of bi-weekly gemcitabine and irinotecan as second-line chemotherapy in non-small cell lung cancer after prior taxane

✍ Christos Kosmas; Nicolas Tsavaris; Konstantinos Syrigos; Angelos Koutras; George 📂 Article 📅 2006 🏛 Springer 🌐 English ⚖ 324 KB

A phase II trial of weekly chemotherapy

A phase II trial of weekly chemotherapy with paclitaxel plus gemcitabine as a first-line treatment in advanced non-small-cell lung cancer

✍ Kiyoshi Mori; Hiroyuki Kobayashi; Yukari Kamiyama; Yasuhiko Kano; Tetsuro Kodama 📂 Article 📅 2008 🏛 Springer 🌐 English ⚖ 268 KB